These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9298104)

  • 1. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei.
    Matsuzaki T; Nagata Y; Kado S; Uchida K; Kato I; Hashimoto S; Yokokura T
    APMIS; 1997 Aug; 105(8):643-9. PubMed ID: 9298104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice.
    Matsuzaki T; Nagata Y; Kado S; Uchida K; Hashimoto S; Yokokura T
    APMIS; 1997 Aug; 105(8):637-42. PubMed ID: 9298103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice.
    Matsuzaki T; Yamazaki R; Hashimoto S; Yokokura T
    Endocr J; 1997 Jun; 44(3):357-65. PubMed ID: 9279510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effects of andrographolide on the development of diabetes in autoimmune diabetic NOD mice by inducing immune tolerance.
    Zhang C; Gui L; Xu Y; Wu T; Liu D
    Int Immunopharmacol; 2013 Aug; 16(4):451-6. PubMed ID: 23707775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
    Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
    Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
    Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
    Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
    Jiang TJ; Zhou ZG; Su H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13 prevents autoimmune diabetes in NOD mice.
    Zaccone P; Phillips J; Conget I; Gomis R; Haskins K; Minty A; Bendtzen K; Cooke A; Nicoletti F
    Diabetes; 1999 Aug; 48(8):1522-8. PubMed ID: 10426368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
    Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
    Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
    Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
    Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice.
    Saï P; Damagé C; Rivereau AS; Hoeltzel A; Gouin E
    J Autoimmun; 1996 Dec; 9(6):713-22. PubMed ID: 9115573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
    Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice.
    Zunino SJ; Storms DH; Stephensen CB
    J Nutr; 2007 May; 137(5):1216-21. PubMed ID: 17449584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
    Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
    J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
    Saï P; Rivereau AS
    Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated protein C inhibits pancreatic islet inflammation, stimulates T regulatory cells, and prevents diabetes in non-obese diabetic (NOD) mice.
    Xue M; Dervish S; Harrison LC; Fulcher G; Jackson CJ
    J Biol Chem; 2012 May; 287(20):16356-64. PubMed ID: 22447930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.